Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases

• Published in: Nature communications Vol. 15; no. 1; pp. 10688 - 12
• Main Authors: Seremet, Teofila, Di Domizio, Jeremy, Girardin, Antoine, Yatim, Ahmad, Jenelten, Raphael, Messina, Francesco, Saidoune, Fanny, Schlapbach, Christoph, Bogiatzi, Sofia, Minisini, Frederic, Garzorz-Stark, Natalie, Leuenberger, Matthieu, Wüthrich, Héloise, Vernez, Maxime, Hohl, Daniel, Eyerich, Stefanie, Eyerich, Kilian, Guenova, Emmanuella, Paul, Carle, Gottardo, Raphael, Conrad, Curdin, Gilliet, Michel
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 18.12.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 38; 38/39; 45/90; 631/250/2502; 631/250/347; 692/4017; 692/53/2421; 692/699/4033; Customization; Diagnosis; Diagnostic systems; Gene expression; Gene Expression Profiling - methods; Gene Regulatory Networks; Helper cells; Humanities and Social Sciences; Humans; Inflammation - diagnosis; Inflammation - genetics; Inflammation - immunology; Leukocytes (eosinophilic); Leukocytes (neutrophilic); Lymphocytes T; Medical treatment; Modules; multidisciplinary; Precision medicine; Precision Medicine - methods; Science; Science (multidisciplinary); Skin - immunology; Skin - pathology; Skin diseases; Skin Diseases - diagnosis; Skin Diseases - genetics; Skin Diseases - immunology; Skin Diseases - therapy; Th2 Cells - immunology; Transcriptome
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-024-54559-6

Previous advances have identified immune pathways associated with inflammatory skin diseases, leading to the development of targeted therapies. However, there is a lack of molecular approaches that delineate these pathways at the individual patient level for personalized diagnostic and therapeutic guidance. Here, we conduct a cross-comparison of expression profiles from multiple inflammatory skin diseases to identify gene modules defining relevant immune pathways. Seven modules are identified, representing key immune pathways: Th17, Th2, Th1, Type I IFNs, neutrophilic, macrophagic, and eosinophilic. These modules allow the development of a molecular map with high diagnostic efficacy for inflammatory skin diseases and clinico-pathologically undetermined cases. Aligning dominant modules with treatment targets offers a rational framework for treatment selection, improving response rates in both treatment-naïve patients and non-responders to targeted therapies. Overall, our approach offers precision medicine for inflammatory skin diseases, utilizing transcriptional modules to support diagnosis and guide personalized treatment selection. Immune gene expression analysis can help differentiate between inflammatory skin diseases. Here the authors compare expression profiles between different human inflammatory skin diseases and identify gene modules such as cytokines or inflammatory mediators and a molecular map to assist in diagnosis and treatment.